News
If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...
Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...
Among patients receiving semaglutide for obesity management, the risk for muscle loss may be higher in older adults and women ...
Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older ...
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
4h
India Today on MSNA complete guide to weight loss using anti-obesity GLP-1 medicationsThe launch of GLP-1 weight-loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for ...
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...
Semaglutide, also known by the brand names Ozempic and Wegovy, is quickly becoming a popular weight-loss medication. (Getty Images) Like nearly 50% of Americans, Talia (not her real name) had ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Myth 6: Semaglutide is a permanent solution to weight loss. Many believe that once they start semaglutide, they’ll be set for life. Unfortunately, that’s not the case.
Semaglutide, a weight-loss drug, showed promise for treating obesity in recent research. Demand quickly exceeded supply after the FDA in June approved once-weekly semaglutide injections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results